ZYDUSLIFE

**

** – Zydus Lifesciences has signed an **MoU with APOLLOHOSP** to expand access to the **Shield™ Multi-Cancer Detection (MCD) Test** across India. The collaboration aims to make **early cancer screening** more accessible by leveraging Apollo Hospitals' nationwide healthcare network and Zydus' diagnostics capabilities. ### Impact on Stocks ** :** Positive – Strengthens its diagnostics and oncology portfolio, expands preventive healthcare offerings, and creates long-term growth opportunities. **Apollo Hospitals:** Positive – Enhances its preventive healthcare services, reinforces its leadership in advanced diagnostics, and could drive higher patient engagement. **Overall View:** **Positive for both Zydus Lifesciences and Apollo Hospitals**, as the partnership supports growth in preventive oncology and advanced cancer diagnostics in India.